Clinical Updates

In a paper published online today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal… »   

The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial… »   

Eliminating tens of thousands of manual lab experiments, two University of Houston (UH) professors are working toward a method to… »   

The U.S. Food and Drug Administration (FDA) has approved the first drug to aid in the prevention of premature birth.… »   

A pair of tumor-inhibiting drugs more than doubled the progression-free survival time for patients with a rare type of pancreatic… »   

A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a… »   

Using skin cells taken from children with a rare heart defect, U.S. researchers have created beating heart cells in the… »   

Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase… »   

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by… »   

Using mathematical concepts, Princeton researchers have developed a method of discovering new drugs for a range of diseases by calculating… »   

Optimer Pharmaceuticals Inc said it signed a licensing deal for its experimental antibiotic, fidaxomicin, with Japanese drugmaker Astellas Pharma Inc’s… »   

Kids who have had certain vaccines might be less likely to develop cancer, especially one type of leukemia, suggests a… »   

Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic, but is too expensive for… »   

Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of treatment-related death when the… »   

Frontotemporal dementia is caused by a breakdown of nerve cells in the frontal and temporal region of the brain (fronto-temporal… »